Aiforia
What They Do edit
AI-powered pathology platform for analyzing tissue samples. Received European approval for AI-assisted breast cancer diagnosis. Used in hospital laboratories across Europe.
Funding edit
Valuation: ~€100M+ (Nasdaq-listed) Multiple rounds. Publicly listed on Nasdaq Helsinki.
Revenue edit
Source: allabolag.se / company reports